Overview
- Deal Type: Sell-Side Advisory
- Company: The Weinberg Group
- Industry: Health & Wellness
- Profile: Leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. For more than 35 years, The Weinberg Group has used scientific and regulatory acumen to provide FDA-focused regulatory and compliance services.
- Headquarters: Washington D.C.
- Outcome: The Weinberg Group was acquired by ProPharma Group, a portfolio company of Linden Capital Partners. The Weinberg Group aligns perfectly with ProPharma Group’s portfolio of high-value services for life science companies.
I would recommend that business owners choose an investment banking partner that understands that selling their business is one of the most significant moments in their lives; SDR provided exactly that perspective for me.
Matthew Weinberg
Former Owner of The Weinberg Group